| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |